Correction: McLoughlin, E.C.; O’Boyle, N.M. Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review. Pharmaceuticals 2020, 13, 8

McLoughlin, Eavan C.; O’Boyle, Niamh M.

doi:10.3390/ph13040072

Open AccessCorrection

Correction: McLoughlin, E.C.; O’Boyle, N.M. Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review. Pharmaceuticals 2020, 13, 8

by

Eavan C. McLoughlin

^*

and

Niamh M. O’Boyle

School of Pharmacy and Pharmaceutical Sciences, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin D02, Ireland

^*

Author to whom correspondence should be addressed.

Pharmaceuticals 2020, 13(4), 72; https://0-doi-org.brum.beds.ac.uk/10.3390/ph13040072

Submission received: 9 April 2020 / Accepted: 13 April 2020 / Published: 20 April 2020

(This article belongs to the Special Issue Recent Contributions in Medicinal Chemistry Within European GP2A Network)

Download Versions Notes

We, the authors, wish to make the following corrections to our paper [1]:

The compound with the code name BAL27862 is Avanbulin, not Plinabulin.

This affects:

Table 1 (page 25) – the entry for Plinabulin should not have BAL27862 after it. This entry refers to Plinabulin (BPI-2358) in clinical trials. The structural features listed alongside this entry are incorrect (refer to 75, avanbulin). The structural features of Plinabulin include a piperazinedione structure.

The structure of Plinabulin not currently included in the text. The structure is shown below for reference:

Table 1 (page 25) – entry for Lisavanbulin should state “Lysine prodrug of Avanbulin (75)” in column 3 (structural features).

Page 26 – Section 5.6 refers to Avanbulin (BAL27862) (75).

The last line of Section 5.6 should be removed (“It is also known as plinabulin and is now in clinical trials.”) It should read: “It is also known as avanbulin.”

Page 32 – Section 6.2.2.

This paragraph refers to Beyond Spring’s compound, Plinabulin (provisional name BPI-2358, formerly NPI-2358). References to BAL27862 and 75 should be removed from this paragraph (first line).

Page 33 – Section 6.2.3.

The first line should read “... prodrug of BAL27862/avanbulin (75, Figure 11) ...” (i.e., plinabulin changed to avanbulin).

The authors would like to apologize for any inconvenience caused to the readers by these changes.

Acknowledgments

We thank Basilea Pharmaceutica International Ltd. for pointing out the error.

Reference

McLoughlin, E.C.; O’Boyle, N.M. Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review. Pharmaceuticals 2020, 13, 8. [Google Scholar] [CrossRef] [PubMed] [Green Version]

© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

Share and Cite

MDPI and ACS Style

McLoughlin, E.C.; O’Boyle, N.M. Correction: McLoughlin, E.C.; O’Boyle, N.M. Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review. Pharmaceuticals 2020, 13, 8. Pharmaceuticals 2020, 13, 72. https://0-doi-org.brum.beds.ac.uk/10.3390/ph13040072

AMA Style

McLoughlin EC, O’Boyle NM. Correction: McLoughlin, E.C.; O’Boyle, N.M. Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review. Pharmaceuticals 2020, 13, 8. Pharmaceuticals. 2020; 13(4):72. https://0-doi-org.brum.beds.ac.uk/10.3390/ph13040072

Chicago/Turabian Style

McLoughlin, Eavan C., and Niamh M. O’Boyle. 2020. "Correction: McLoughlin, E.C.; O’Boyle, N.M. Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review. Pharmaceuticals 2020, 13, 8" Pharmaceuticals 13, no. 4: 72. https://0-doi-org.brum.beds.ac.uk/10.3390/ph13040072

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Menu

Correction: McLoughlin, E.C.; O’Boyle, N.M. Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review. Pharmaceuticals 2020, 13, 8

Acknowledgments

Reference

Share and Cite

Article Metrics

Article Access Statistics

Further Information

Guidelines

MDPI Initiatives

Follow MDPI